
Super User
Sunday, 08 August 2021 11:20
Wen-zhao Zhong
Positions and Employment
Chief Physician, Thoracic Neoplasms Surgery.
Deputy Director, Guangdong Lung Cancer Institute;
Doctoral Supervisor, South China University of Technology
Doctoral Supervisor, Southern Medical University
Master Supervisor , Shantou University
Director, Vice Chairman of the Youth Commission
Chief, Lung Cancer Specialist Group of Chinese Society of Clinical Oncology
Deputy Leader , the Cancer Early Diagnosis and Treatment Group of Chinese Medical Association;
Associate Editor , JTO (J Thorac Oncol) , the Official Journal of the International Association for the Study of Lung Cancer (IASLC)
He is mainly engaged in lung cancer surgery-oriented single disease multidisciplinary comprehensive treatment, including stage IIIA-N2 Lung Cancer, classification diagnosis and treatment of solitary pulmonary nodule/adenocarcinoma of lung/GGO, minimally invasive thoracoscopic radical resection of lung cancer, pathological classification of lung cancer and clinical practice, artificial intelligence image-liquid biopsy for lung cancer and early screening and diagnosis system, etc. He has undertaken four research projects supported by the National Natural Science Foundation of China (i.e. Molecular evolution of targeted drug resistant molecule T790M-2010; molecular evolution of lung adenocarcinoma-2013; Molecular heterogeneity of high-grade neuroendocrine neoplasm DLL3-2016; radiomics in precise treatment of lung cancer-2018); the research results of these four projects were published in journals like lancet oncol , JCO , J Thorac Oncol, CCR, Cancer, Oncologist, Lung Cancer, JHO, Eur J Cardiothorac Surg, Ann Surg Oncol, BMC Cancer, Clin Lung Cancer, Cancer Lett,etc.
Chief Physician, Thoracic Neoplasms Surgery.
Deputy Director, Guangdong Lung Cancer Institute;
Doctoral Supervisor, South China University of Technology
Doctoral Supervisor, Southern Medical University
Master Supervisor , Shantou University
Director, Vice Chairman of the Youth Commission
Chief, Lung Cancer Specialist Group of Chinese Society of Clinical Oncology
Deputy Leader , the Cancer Early Diagnosis and Treatment Group of Chinese Medical Association;
Associate Editor , JTO (J Thorac Oncol) , the Official Journal of the International Association for the Study of Lung Cancer (IASLC)
He is mainly engaged in lung cancer surgery-oriented single disease multidisciplinary comprehensive treatment, including stage IIIA-N2 Lung Cancer, classification diagnosis and treatment of solitary pulmonary nodule/adenocarcinoma of lung/GGO, minimally invasive thoracoscopic radical resection of lung cancer, pathological classification of lung cancer and clinical practice, artificial intelligence image-liquid biopsy for lung cancer and early screening and diagnosis system, etc. He has undertaken four research projects supported by the National Natural Science Foundation of China (i.e. Molecular evolution of targeted drug resistant molecule T790M-2010; molecular evolution of lung adenocarcinoma-2013; Molecular heterogeneity of high-grade neuroendocrine neoplasm DLL3-2016; radiomics in precise treatment of lung cancer-2018); the research results of these four projects were published in journals like lancet oncol , JCO , J Thorac Oncol, CCR, Cancer, Oncologist, Lung Cancer, JHO, Eur J Cardiothorac Surg, Ann Surg Oncol, BMC Cancer, Clin Lung Cancer, Cancer Lett,etc.
Published in
Speakers
Tagged under